Combined Vitrectomy and Femtosecond Laser-assisted Cataract Surgery

Last updated: October 17, 2022
Sponsor: Aier School of Ophthalmology, Central South University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Hemorrhage

Eye Disorders/infections

Macular Degeneration

Treatment

N/A

Clinical Study ID

NCT05588037
SHIRB2018019
  • Ages > 18
  • All Genders

Study Summary

Based on the progress of cataract surgery, intraocular lens development, vitreoretinal surgery and anesthesia technology in recent years, the purpose of this study is to develop a new type of more accurate and minimally invasive combined surgery for cataract and fundus diseases, and to evaluate the advantages and value of the surgery as well as related complications, so as to minimize the surgical trauma and obtain faster visual function recovery and better patient comfort. To provide new solutions for the growing demand of eye health care.

Eligibility Criteria

Inclusion

Inclusion Criteria: clinical diagnosis of following disease

  • RRD with cataract
  • ERM with cataract
  • MH with cataract
  • Vitreous opacity with cataract

Exclusion

Exclusion Criteria: patients with history of following condition

  • intraocular surgery
  • ocular trauma
  • endophthalmitis
  • uveitis
  • glaucoma

Study Design

Total Participants: 100
Study Start date:
January 01, 2017
Estimated Completion Date:
December 31, 2023

Study Description

To evaluate the efficacy and complications of a new type of minimally invasive femtosecond laser assisted-cataract surgery (FLACS) combined with pars plana vitrectomy (PPV) with two-step anesthesia in the treatment of various common fundus diseases such as rhegmatogenous retinal detachment (RRD), epiretinal membrane (ERM), macular hole (MH), and vitreous opacity, complicated with cataract. It is mainly aimed at the following kinds of common fundus diseases with cataract performing PPV and cataract removal combined with monofocal or premium intraocular lens (IOL) implantation： RRD complicated with cataract: FLACS +PPV + IOL+air; ERM complicated with cataract: FLACS +PPV+IOL + epiretinal membrane peeling + Ozurdex; MH complicated with cataract: FLACS + PPV+ IOL + internal limiting membrane peeling + air; Vitreous opacity with cataract: FLACS + PPV+ IOL.

Connect with a study center

  • Jiasong Yang

    Shanghai, 200000
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.